Statin drugs have made history for their blockbuster sales, and their use is only expected to increase when Lipitor's patent soon expires. But, for millions of people, statins simply don't do enough. Melinda Wenner Moyer explores ongoing efforts to develop new cholesterol-lowering drugs in light of clues that cardiovascular health is more complicated than doctors once thought.
